Covid-19 roundup: Pfizer-BioNTech ask for kid booster EUA; Novartis, Molecular Partners may need another trial for pandemic therapy

As both the debate and pressure remain around giving the youngest children a first dose of the Covid-19 vaccine, Pfizer and BioNTech are moving …

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Covid-19 roundup: Pfiz­er-BioN­Tech ask for kid boost­er EUA; No­var­tis, Mol­e­c­u­lar Part­ners may need an­oth­er tri­al for pan­dem­ic ther­a­py